Clinical Trial Update: Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing oxaliplatin with S-1 versus oxaliplatin with capecitabine for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Colorectal Neoplasm | Phase 2 | Status: COMPLETED